A study of non-toxic goitre

Area of Science:

• Endocrinology
• Thyroidology
• Clinical Medicine

Background:

• Non-toxic goitres have a population prevalence of 2.8%.
• The clinical significance of non-toxic goitres requires further definition.
• Previous research has not adequately established the clinical implications of non-toxic goitres.

Purpose of the Study:

• To define the clinical significance of non-toxic goitres.
• To classify non-toxic goitres into diffuse, lobular, and nodular types.
• To investigate associations with thyroid antibodies and malignancy risk.

Main Methods:

• Clinical classification of 64 patients with non-toxic goitres.
• Assessment of thyroid antibodies, radioisotope scanning, ultrasonography, and fine-needle aspiration cytology.
• Categorization into diffuse (gp1), lobular (gp2), and nodular (gp3) groups.

Main Results:

• Nodular goitres constituted 69% of cases, with 70% having a single nodule.
• Multinodularity was observed in diffuse and lobular goitres.
• Antithyroid antibodies were detected in 20% of gp2 and 7% of gp3.
• Malignancy was identified in 2% of gp2 and 11% of gp3.

Conclusions:

• Non-toxic goitres, particularly nodular types, warrant thorough investigation.
• The study highlights varying risks of malignancy and antibody presence across goitre classifications.
• A management strategy for non-toxic goitre was proposed based on these findings.